Structure Therapeutics (GPCR) Retained Earnings (2022 - 2026)

Structure Therapeutics' Retained Earnings history runs 5 years deep, the most recent figure standing at -$546.3 million for Q1 2026.

• On a quarterly basis, Retained Earnings fell 145.53% year-over-year to -$546.3 million in Q1 2026; TTM through Mar 2026 was -$546.3 million, a 145.53% decrease from a year earlier, with the FY2025 full-year figure at -$470.3 million, down 51555.14% from the prior year.
• Retained Earnings eased to -$546.3 million in Q1 2026 per GPCR's latest filing, from -$470.3 million in the prior quarter.
• Across five years, Retained Earnings topped out at $1.3 billion in Q3 2025 and bottomed at -$546.3 million in Q1 2026.
• The 5-year median for Retained Earnings is -$146.6 million (2023), against an average of $139.2 million.
• Across the five-year window, Retained Earnings jumped 663.48% in 2023 and sank 51555.14% in 2025, its largest moves.
• Year by year, Retained Earnings stood at -$117.0 million in 2022, then soared by 663.48% to $659.0 million in 2023, then tumbled by 99.86% to $914000.0 in 2024, then sank by 51555.14% to -$470.3 million in 2025, then decreased by 16.16% to -$546.3 million in 2026.
• Per Business Quant, the three latest GPCR Retained Earnings figures stand at -$546.3 million (Q1 2026), -$470.3 million (Q4 2025), and $1.3 billion (Q3 2025).